A new brain cancer atlas maps out comprehensive, visually rich information about the anatomical and genetic bases of glioblastoma, researchers report.
COVID-19 breakthrough cases that result in severe infection, hospitalization, or death are more likely in those with cancer and Alzheimer's patients.
Researchers used the HoloLense software to create an interactive holographic mapping system for axonal pathways in the human brain.
Researchers have identified a link between misshapen, fast replicating tau proteins, and accelerated cognitive decline. The findings shed new light on the development and progression of Alzheimer's disease.
Researchers say the 4.5 million-year old fossil shows evidence of greater reliance on bipedalism than previously suggested.
Researchers have successfully created a synthetic version of a human prion, a protein associated with brain wasting diseases like sporadic Creutzfeldt-Jakob disease. The prions may help shed new light on, and provide treatment options, for those with CJD and other prion related diseases.
Cryogenic-electron microscopy allowed researchers to determine the basic building blocks of prion proteins, including the placements of their amino acids.
Researchers report T cells in Parkinson's disease patients respond to alpha synuclein to a greater degree than those without the disease. The Nature study reports four genetic variations are associated with T cell reactivity to alpha synuclein. More than 50% of Parkinson's patients carry at least one of the gene variants.
A new prosthetic system allows amputees to feel the same intensity of pressure on their prosthetic hand as they can feel with their natural hand.
Researchers have identified three regions in the genome where significant genetic differences between the sexes exist. These differences also varied by cancer type. The findings suggest specific genetic tests tailored to the different sexes could help assess cancer risks.
A mouse study reveals nerve cells damaged as a result of diabetes may not be repairable due to low levels of specific cytokines.
Researchers have developed a new algorithm that integrates Alzheimer's indicators from MRI measurements to predict patients with the neurodegenerative disease.
